Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Optimizing treatment for adhesive small bowel obstruction

Official title: The Use of Nasogastric Tubes And Water-Soluble Contrast In The Management Of Small Bowel Obstruction: A Feasibility Study

Run by University of California, Los Angeles · NCT06182319 · Data updated 2026-11-12

This study is testing whether using nasogastric tubes or water-soluble contrast can improve treatment for adults with adhesive small bowel obstruction and help them feel better.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity of California, Los Angeles
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedDecember 15, 2025
Study endsDecember 15, 2025
Registry record updatedMay 8, 2024
Trial IDNCT06182319 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with documented adhesive small bowel obstruction.

Probably not a fit

Patients with nonadhesive small bowel obstruction or those with certain serious medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to improve the treatment protocols for adhesive small bowel obstruction (aSBO), a common gastrointestinal issue. It will assess the feasibility of randomizing patients to receive either nasogastric tubes (NGTs) or water-soluble contrast (WSC) as part of their treatment. The study will also focus on measuring health-related quality of life (HRQOL) as a primary outcome, addressing critical gaps in understanding who benefits from NGT placement and how to manage feeding reintroduction. The trial will involve patients aged 18 and older who exhibit clinical features of aSBO.

Why it matters

Potential benefit: If successful, this study could lead to more effective and tailored treatment options for patients suffering from adhesive small bowel obstruction.

How similar studies have gone: Other studies have explored treatment protocols for bowel obstructions, but this specific approach to optimizing aSBO treatment is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male or female ≥18 years of age.
2. Documentation of aSBO as evidenced by one or more clinical features meeting the following criteria: Nausea, emesis, abdominal pain, distended abdomen CT evidence of aSBO

Exclusion Criteria:

1. Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study.
2. Presence of a condition or abnormality that in the opinion of the investigator would compromise the safety of the patient or the quality of the data.
3. Unstable angina or recent myocardial infarction (MI)/stroke within 6 months
4. Nonadhesive SBO

   1. Paralytic Ileus
   2. Incarcerated hernia
   3. Fecal impaction
   4. Intra-abdominal malignancy Early aSBO within 4 weeks of a prior abdominal operation

Where it's running

  • University of California, Los Angeles, David Geffen School of Medicine
    Los Angeles, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.